ALBAlbemarle Corporation
$99.25+2.2% 1Y
$99.25
$87.7452 weeks$215.07
The business
How ALB's business earns
Albemarle Corporation earns 4.6% on the capital it employs against an estimated 9.0% cost of capital.
4.6%
Return on invested capital · cost of capital 9.0% · 4.4 points below the estimated cost of capital
- Operating margin
- 10%
Operating margin · Specialty Chemicals median 8.6% · 12 months to Sep 30, 2026
- Cash conversion
- 3.79×
Cash conversion · operating cash flow divided by operating profit after tax
- Share count, year on year
- +0.73%
Share count, year on year · within 1% of a year ago
Operating margin by fiscal year
| Year | Operating margin |
|---|---|
| FY2020 | 16% |
| FY2021 | 24% |
| FY2022 | 34% |
| FY2023 | 2.6% |
| FY2024 | −33% |
| FY2025 | −7.1% |
Details›
- Gross margin12 months to Sep 30, 2026
- 26%
- Operating margin12 months to Sep 30, 2026
- 10%
- Net margin12 months to Sep 30, 2026
- 11%
- Free cash flow margin
- 23%
- R&D as % of revenue
- 0.54%
- Revenue, trailing twelve months
- $6.15B
- Free cash flow, trailing twelve months
- $1.44B
- Net income, trailing twelve months
- $682M
- Return on invested capitaloperating profit after tax ÷ debt + equity − cash
- 4.6%
Margins, capital and share counts from the statements as filed with the SEC; cash conversion is operating cash flow over operating profit after tax.
Specialty Chemicals
The closest names by size in the same industry